WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997037035) WHOLE BLOOD ANALYSIS OF PROSTATE SPECIFIC ANTIGEN SPOTTED ON A SOLID SUPPORT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/037035    International Application No.:    PCT/US1997/005368
Publication Date: 09.10.1997 International Filing Date: 25.03.1997
Chapter 2 Demand Filed:    23.10.1997    
IPC:
G01N 33/574 (2006.01), G01N 33/68 (2006.01)
Applicants: DIAGNOSTIC SYSTEMS LABORATORIES, INC. [US/US]; 445 Medical Center Boulevard, Webster, TX 77498-4217 (US)
Inventors: SAVJANI, Gopal, V.; (US)
Agent: VALOIR, Tamsen; Jenkens & Gilchrist, Suite 1800, 1100 Louisiana, Houston, TX 77002 (US)
Priority Data:
08/626,641 02.04.1996 US
Title (EN) WHOLE BLOOD ANALYSIS OF PROSTATE SPECIFIC ANTIGEN SPOTTED ON A SOLID SUPPORT
(FR) ANALYSE DE L'ANTIGENE SPECIFIQUE DE LA PROSTATE DANS UN EXTRAIT DE SANG ENTIER SUR UN SUPPORT SOLIDE
Abstract: front page image
(EN)The present invention provides for the measurement of prostate specific antigen (PSA) from extracts of blood dried on a suitable solid support. PSA in solid support dried blood is stable for more than 100 days at room temperature. The procedure of the present invention can reliably distinguish normal from elevated levels of PSA and that facilitates screening and monitoring to detect disease in large scale mail-in programs to centralized laboratories.
(FR)L'invention concerne un procédé consistant à mesurer l'antigène spécifique de la prostate (PSA) depuis des extraits de sang séché sur un support solide approprié. Cet antigène (PSA) dans du sang séché sur un support solide présente une stabilité supérieure à 100 jours à température ambiante. Ce procédé permet d'établir une distinction fiable entre des niveaux normaux et des niveaux élevés de PSA et facilite le contrôle et la recherche, afin de détecter la maladie lors de programmes à grande échelle d'envoi de spécimens à des laboratoires centralisés.
Designated States: AL, AM, AT, AU, AZ, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, UZ, VN.
African Regional Intellectual Property Organization (GH, KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)